Autres langues North China Pharmaceutical Company.Ltd

Actions

600812

CNE000000D16

Produits pharmaceutiques

Cours en clôture Shanghai S.E. Autres places de cotation 07/08/2026			Varia. 5j.	Varia. 1 janv.
4,960 ^CNY	+4,20%		+2,90%	-10,31%

04/08	Huit produits de North China Pharmaceutical remportent les enchères préliminaires du programme public d'achats groupés de médicaments	MT
25/05	North China Pharma reçoit le feu vert de la Chine pour un traitement de l'anémie rénale	MT

Autres langues

04/08	North China Pharmaceutical's Eight Products Win Preliminary Bids Under Government Drug Procurement Program
25/05	North China Pharma Gets China Nod for Kidney Anemia Drug
24/04	North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026
20/04	North China Pharmaceutical Company.Ltd announces Annual dividend, payable on June 11, 2026
17/04	North China Pharmaceutical Company.Ltd Reports Earnings Results for the Full Year Ended December 31, 2025
07/04	North China Pharmaceutical Receives Compensation for Government Land Expropriation
05/11	North China Pharmaceutical Subsidiary Gets China Marketing Approval for Antibiotic
24/10/25	North China Pharmaceutical Company.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025
17/09/25	North China Pharmaceutical Gets Nod to Market Imipenem, Cilastatin Sodium for Injection
03/09/25	North China Pharmaceutical Gets Approval for Antibiotic
13/08/25	North China Pharmaceutical Company.Ltd Reports Earnings Results for the Half Year Ended June 30, 2025
30/07/25	North China Pharmaceutical Gets China Approval for Adenosylcobalamin Capsule
11/06/25	North China Pharmaceutical Registers Ceftazidime and Avibactam Sodium for Injection
06/06/25	North China Pharmaceutical Gets Registration Certificate for Isavuconazonium Sulfate for Injection
22/05/25	North China Pharmaceutical Signs Financial Services Deal With Jizhong Energy Group Finance
23/04/25	North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2025
27/03/25	North China Pharmaceutical Company.Ltd Reports Earnings Results for the Full Year Ended December 31, 2024
27/03/25	North China Pharmaceutical Company.Ltd announces Annual dividend, payable on July 25, 2025
13/03/25	North China Pharmaceutical Secures EU GMP Certification
25/02/25	North China Pharmaceutical Subsidiary Passes GMP Compliance Inspection
17/12/24	North China Pharmaceutical Withdraws Drug Registration for Antibiotic
25/10/24	North China Pharmaceutical Company.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2024
03/10/24	North China Pharmaceutical's Unit Gets Nod to Register HIV Drug
13/08/24	North China Pharmaceutical Company.Ltd Reports Earnings Results for the Half Year Ended June 30, 2024
03/06/24	China Grants Marketing Approval for Ampicillin Sodium as Active Pharmaceutical Ingredient